These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7518835)

  • 1. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
    Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
    J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
    Bhatia R; McCarthy JB; Verfaillie CM
    Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.
    Bhatia R; McGlave PB; Verfaillie CM
    J Clin Invest; 1995 Aug; 96(2):931-9. PubMed ID: 7543495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation.
    Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
    Leukemia; 1997 Jun; 11(6):822-9. PubMed ID: 9177435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia.
    Bhatia R; Verfaillie CM
    Leuk Lymphoma; 1998 Jan; 28(3-4):241-54. PubMed ID: 9517496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
    Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
    Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
    Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
    Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
    Verfaillie CM; McCarthy JB; McGlave PB
    J Clin Invest; 1992 Oct; 90(4):1232-41. PubMed ID: 1383271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Exp Hematol; 1999 Sep; 27(9):1384-96. PubMed ID: 10480429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells.
    Dowding C; Guo AP; Osterholz J; Siczkowski M; Goldman J; Gordon M
    Blood; 1991 Jul; 78(2):499-505. PubMed ID: 1906352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia.
    Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF
    Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
    Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?
    Verfaillie CM; Hurley R; Zhao RC; Prosper F; Delforge M; Bhatia R
    J Lab Clin Med; 1997 Jun; 129(6):584-91. PubMed ID: 9178724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia.
    Budak-Alpdoğan T; Alpdoğan O; Akoğlu T
    Am J Hematol; 1999 Dec; 62(4):212-20. PubMed ID: 10589076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR/ABL induces multiple abnormalities of cytoskeletal function.
    Salgia R; Li JL; Ewaniuk DS; Pear W; Pisick E; Burky SA; Ernst T; Sattler M; Chen LB; Griffin JD
    J Clin Invest; 1997 Jul; 100(1):46-57. PubMed ID: 9202056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.
    Bhatia R; Munthe HA; Forman SJ
    Br J Haematol; 2001 Dec; 115(4):845-53. PubMed ID: 11843818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
    Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
    Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.